{"title":"<i>LMNA-NTRK1</i> fusion-positive MSI-high colorectal cancer responding to FOLFOX plus bevacizumab after immune checkpoint inhibitor failure: a case report.","authors":"Kentaro Sawada, Ryosuke Watanabe, Kohei Okamoto, Morioh Kon, Hiroki Yonemura, Yusuke Nishimura, Shunichi Hosoda, Shun Takahashi, Takeaki Nakamura, Hisashi Oda, Takuto Miyagishima","doi":"10.1007/s13691-026-00909-8","DOIUrl":"10.1007/s13691-026-00909-8","url":null,"abstract":"<p><p>A 63-year-old woman with microsatellite instability-high metastatic colorectal cancer experienced tumor enlargement and worsening general condition after the first dose of pembrolizumab. This was determined to represent true progression rather than pseudoprogression. Second-line treatment with fluorouracil, leucovorin, and oxaliplatin plus bevacizumab achieved a complete response sustained for over three years. Comprehensive genomic profiling testing performed during chemotherapy detected a <i>lamin A/C</i>-<i>neurotrophic tyrosine receptor kinase (NTRK) 1</i> fusion, and <i>NTRK</i> targeted therapy is planned at the time of the next progression. This case report provides valuable information on the clinical course of this rare molecular subtype and emphasizes the importance of comprehensive genomic profiling for detecting <i>NTRK</i> fusions, which, although rare overall, are relatively more frequent in MSI-high than in microsatellite-stable colorectal cancer.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"601-607"},"PeriodicalIF":0.4,"publicationDate":"2026-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13597976/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In the shadow of bone: calvarial metastasis unmasking the undiagnosed prostate adenocarcinoma: a case report.","authors":"Mamatha K, Vishal Varma Pandurala, M S Kotennavar","doi":"10.1007/s13691-026-00914-x","DOIUrl":"10.1007/s13691-026-00914-x","url":null,"abstract":"<p><p>Prostate adenocarcinoma commonly metastasizes to the axial skeleton; however, calvarial metastasis is an exceptionally rare manifestation, particularly as the initial presentation of an otherwise undiagnosed malignancy. Calvarial metastases may mimic neurological, infectious, or primary skull lesion, often resulting in a diagnostic delay. We report here a case of 75-year-old male who presented with a progressively enlarging, painless swelling over the right frontal region associated with headache. Based on the clinical and radiological findings, a provisional diagnosis of <b>osteoma/osteoid osteoma</b> was made, and the patient underwent surgical excision of the lesion for definitive diagnosis. Histopathological examination of the excised lesion revealed features of metastatic adenocarcinoma with focal infiltration into the underlying bone. Based on the histomorphological findings we suspected metastasis from prostate and suggested the further investigations. Serum prostate-specific antigen (PSA) levels were elevated and Ga-PSMA-11 PET scan demonstrated an enlarged prostate with multiple hypermetabolic skeletal lesions which suggested the diagnosis of prostate carcinoma and its metastasis. Subsequently, transrectal ultrasound-guided biopsy of the prostate confirmed prostatic acinar adenocarcinoma .Immunohistochemistry of the calvarial lesion showed positivity for prostate-specific antigen, confirming the diagnosis of metastasis from prostatic adenocarcinoma. This case highlights the rare presentation of calvarial metastasis as the initial manifestation of prostatic adenocarcinoma. As metastases to skull are clinically silent or present with nonspecific symptoms, a high index of suspicion is essential in elderly men with atypical calvarial lesions. Correlation of imaging, histopathology, immunohistochemistry, PET scan and serum PSA is crucial for identifying the primary tumor. This case emphasizes including metastatic prostatic carcinoma in the differential diagnosis of calvarial lesions for timely diagnosis and management.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"651-658"},"PeriodicalIF":0.4,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neuroendocrine carcinoma in gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS).","authors":"Hirotaka Fukushiyama, Chihiro Matsumoto, Kohei Yamashita, Kojiro Eto, Satoshi Ida, Yasuki Sasaoka, Mika Naritomi, Yuji Miyamoto, Yoshihiro Komohara, Masaaki Iwatsuki","doi":"10.1007/s13691-026-00911-0","DOIUrl":"10.1007/s13691-026-00911-0","url":null,"abstract":"<p><p>Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) is a rare hereditary syndrome caused by APC promoter 1B variants, with limited data on advanced disease. We report a 57-year-old woman with genetically confirmed GAPPS who presented with advanced gastric cancer and bulky nodal metastases (cT4aN(+)M0, cStage III). Following three courses of neoadjuvant S-1 plus oxaliplatin, radiological and endoscopic tumor regression was observed, enabling robot-assisted total gastrectomy with R0 resection. Histopathological examination revealed residual adenocarcinoma with fibrosis and necrosis (Grade 1a) alongside a neuroendocrine carcinoma (NEC) component. The final pathological stage was ypT4aN1M0 (ypStage IIIA). This case suggests that tumor evolution in GAPPS may involve neuroendocrine differentiation, thereby broadening the recognized pathological spectrum of GAPPS and highlighting the potential for histological diversification in GAPPS-associated gastric cancer.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"639-645"},"PeriodicalIF":0.4,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Long-term response to mFOLFOX6 in non-ampullary duodenal adenocarcinoma with inferior vena cava tumor thrombus: an autopsy case implicating <i>BRIP1</i> loss.","authors":"Yasuhiro Mitsui, Shota Fujimoto, Megumi Yamasaki, Kengo Atsumi, Koichi Tsuneyama, Hiroshi Miyamoto","doi":"10.1007/s13691-026-00903-0","DOIUrl":"10.1007/s13691-026-00903-0","url":null,"abstract":"<p><p>A 74-year-old Japanese man presented with a left inguinal mass. Esophagogastroduodenoscopy revealed a circumferential non-ampullary duodenal tumor, which was diagnosed as a moderately differentiated adenocarcinoma. Computed tomography demonstrated multiple liver metastases and a tumor thrombus extending from the inferior vena cava (IVC) to the left renal vein, leading to a diagnosis of unresectable advanced non-ampullary duodenal adenocarcinoma, cT4bN0M1 stage IV (UICC-TNM 8th edition). The patient received 10 cycles of mFOLFOX6 therapy, resulting in marked tumor shrinkage; however, treatment was discontinued due to grade 3 peripheral neuropathy (CTCAE v5.0). He subsequently received 12 cycles of sLV5FU2 therapy until disease progression on day 413. Autopsy revealed a moderately differentiated tubular adenocarcinoma with gastric-type features invading the pancreas and IVC, along with multiple hepatic metastases of the same phenotype. Real-time PCR analysis of the primary tumor, liver lesions, and IVC tumor demonstrated markedly reduced <i>BRIP1</i> expression, suggesting homologous recombination deficiency and enhanced sensitivity to platinum-based chemotherapy. To our knowledge, this is the first reported autopsy case of non-ampullary duodenal adenocarcinoma with <i>BRIP1</i> loss showing a prolonged response to mFOLFOX6. This case underscores the potential relevance of molecular profiling in optimizing treatment strategies for rare gastrointestinal cancers.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"575-581"},"PeriodicalIF":0.4,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diffuse large B-cell lymphoma occurring at ileocolonic anastomosis site after right hemicolectomy for colorectal cancer: a case report.","authors":"Tomoya Kurose, Yuzuru Sakamoto, Tetsuhito Muranaka, Hiroki Nakamoto, Takahiro Oshima, Tomoharu Yoshizumi, Akinobu Taketomi","doi":"10.1007/s13691-026-00915-w","DOIUrl":"10.1007/s13691-026-00915-w","url":null,"abstract":"<p><p>Diffuse large B-cell lymphoma is the most common and aggressive type of non-Hodgkin lymphoma, accounting for approximately 30%-40% of cases. It can arise in both nodal and extranodal sites, most commonly in the gastrointestinal tract. Although gastrointestinal diffuse large B-cell lymphoma has been reported, development at a colorectal anastomotic site is extremely rare. A 94-year-old woman with a history of right hemicolectomy for appendiceal adenocarcinoma and prior chemotherapy for B-cell lymphoma involving the left ventricular wall presented with gait instability and severe anemia. Enhanced computed tomography revealed irregular wall thickening at the ileocolonic anastomosis without lymph node or distant metastasis. Colonoscopy showed a friable, stenotic tumor at the anastomotic site. Surgical resection with lymphadenectomy was performed for bleeding control. Histopathological examination demonstrated diffuse proliferation of atypical lymphoid cells positive for CD20 and CD10, supporting a diagnosis of diffuse large B-cell lymphoma. Postoperative chemotherapy was not administered because of advanced age, and no recurrence has been observed to date. This case highlights the importance of considering lymphoma in the differential diagnosis of anastomotic lesions after colorectal surgery because chronic inflammation and mucosal remodeling may contribute to tumor development.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"659-664"},"PeriodicalIF":0.4,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598006/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Interrupted surveillance and delayed genetic evaluation in neurofibromatosis type 1 associated with advanced malignant peripheral nerve sheath tumor and breast cancer: A case report.","authors":"Mihoko Doi, Maiko Tanaka, Kanako Iwami, Mika Uemoto, Hanae Satano, Midori Noma, Takashi Nishisaka, Katsunori Shinozaki","doi":"10.1007/s13691-026-00913-y","DOIUrl":"10.1007/s13691-026-00913-y","url":null,"abstract":"<p><p>Neurofibromatosis type 1 (NF1) is a tumor predisposition syndrome associated with increased risks of malignant peripheral nerve sheath tumors (MPNSTs) and early-onset breast cancer, requiring lifelong surveillance and multidisciplinary management. However, the clinical impact of disrupted surveillance and delayed genetic evaluation in adults with NF1 remains insufficiently described. We report the case of a 37-year-old woman with clinically recognizable NF1 who declined surgical treatment for a cervical plexiform neurofibroma (PN) due to concerns regarding functional impairment and was subsequently lost to follow-up. After 12 years, she presented with an advanced MPNST arising from the PN and synchronous metastatic triple-negative breast cancer. Tumor-normal MPNST sequencing identified a germline pathogenic <i>NF1</i> truncating variant (p.Arg2637*) and a somatic second-hit <i>NF1</i> alteration (p.Leu1505Serfs*63), consistent with biallelic <i>NF1</i> inactivation, along with additional alterations involving <i>EED</i> and <i>CDKN2A</i>/<i>MTAP</i>. We identified no clinically actionable alterations, and standard systemic therapies provided limited clinical benefit. Despite multimodal treatment, the patient died approximately 1 year after diagnosis. This case illustrates how interrupted surveillance and delayed genetic evaluation in NF1 could contribute to the delayed recognition of aggressive malignancies and highlights the importance of genetic counseling, structured longitudinal surveillance, and coordinated multidisciplinary care.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"665-669"},"PeriodicalIF":0.4,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Teruki Yoshida, Sachiko Kitamura, Masahiro Tsuda, Miwa Uesugi, Koji Yamanoi, Masumi Sunada, Mana Taki, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Tomohiro Terada, Masaki Mandai
{"title":"Pharmacokinetic characterization of olaparib tablets in a hemodialysis patient with advanced ovarian cancer: a case report.","authors":"Teruki Yoshida, Sachiko Kitamura, Masahiro Tsuda, Miwa Uesugi, Koji Yamanoi, Masumi Sunada, Mana Taki, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Tomohiro Terada, Masaki Mandai","doi":"10.1007/s13691-026-00907-w","DOIUrl":"10.1007/s13691-026-00907-w","url":null,"abstract":"<p><p>While molecular targeted therapy development has expanded the potential for individualized cancer treatment, the optimal therapeutic strategy for patients with complex comorbidities, including renal impairment, remains insufficiently established. We report a case of advanced ovarian cancer in a patient undergoing maintenance hemodialysis who received olaparib, with serial plasma drug concentration measurements performed to characterize its pharmacokinetic profile and provide insights into safe and effective treatment in patients on hemodialysis. A 65-year-old woman with chronic renal failure who was undergoing thrice-weekly maintenance hemodialysis was diagnosed with stage IVB high-grade serous ovarian carcinoma harboring a pathogenic BRCA1 variant identified by tumor testing. Following the first-line chemotherapy, oral olaparib tablets (300 mg/day) was initiated as maintenance therapy. Plasma olaparib concentrations were measured on dialysis and non-dialysis days. Drug concentrations on both days increased to levels comparable to those reported in the package insert (400 mg/day tablet formulation) and in a previously published case of a hemodialyzing patient receiving 400 mg/day in capsule form. No adverse events other than anemia requiring dose interruption, dose reduction, or treatment discontinuation were observed. The initial dose of 300 mg/day was maintained throughout treatment, enabling continued outpatient management until disease progression occurred 2 months later. In this case, olaparib (300 mg/day) was tolerated and achieved plasma concentrations comparable to those observed in non-dialyzing patients receiving olaparib (400 mg/day). Further evidence regarding the association between plasma olaparib concentrations and toxicity in patients on hemodialysis is warranted to optimize treatment strategies.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13691-026-00907-w.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"612-621"},"PeriodicalIF":0.4,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598062/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shinichiro M Koga, Kansuke Ito, Misako Kusakabe, Yasuyuki Kitahara
{"title":"Long survival in pulmonary tumor thrombotic microangiopathy underscores the need for recognition before severe pulmonary hypertension.","authors":"Shinichiro M Koga, Kansuke Ito, Misako Kusakabe, Yasuyuki Kitahara","doi":"10.1007/s13691-026-00904-z","DOIUrl":"10.1007/s13691-026-00904-z","url":null,"abstract":"","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"675-676"},"PeriodicalIF":0.4,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13597984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Endobronchial typical carcinoid with secondary Aspergillus fumigatus colonization: Avoiding a diagnostic pitfall in bronchoscopic biopsy.","authors":"Yashita Gupta, Dibakar Sahu","doi":"10.1007/s13691-026-00912-z","DOIUrl":"10.1007/s13691-026-00912-z","url":null,"abstract":"<p><p>Endobronchial fungal colonization can obscure an underlying obstructive neoplasm in limited bronchoscopic biopsies, posing a significant diagnostic challenge. We report an immunocompetent 55-year-old woman presenting with an obstructing endobronchial mass whose bronchoscopic biopsy revealed a well-differentiated neuroendocrine neoplasm with abundant septate fungal hyphae confined to necrotic intraluminal debris. Tumour cells showed diffuse synaptophysin, chromogranin A, INSM1 and OTP expression with a Ki-67 proliferation index < 2%, supporting the diagnosis of a typical pulmonary carcinoid. Periodic acid-Schiff and Grocott-Gomori methenamine silver stains highlighted the fungal elements, while fungal culture confirmed <i>Aspergillus fumigatus</i>. The absence of fungal invasion within viable tumour, bronchial stroma or vascular structures favoured secondary colonization rather than tissue-invasive aspergillosis. This case highlights the importance of integrating histomorphology, ancillary investigations and microbiological findings, and emphasizes meticulous evaluation of viable tissue to avoid overlooking an underlying obstructing neoplasm.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"646-650"},"PeriodicalIF":0.4,"publicationDate":"2026-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598051/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}